Financhill
Back

Sarepta Therapeutics Vs. Regeneron Pharmaceuticals Industry Stock Comparison

Sell
33

SRPT
Sarepta Therapeutics

Last Price:
114.28
Seasonality Move:
16.38%
Sell
39

REGN
Regeneron Pharmaceuticals

Last Price:
737.85
Seasonality Move:
14.6%
Sell
33
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $114.23. The Score for SRPT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Regeneron Pharmaceuticals (REGN) is a Sell

Is Regeneron Pharmaceuticals a Buy, Sell or Hold?

  • The current Regeneron Pharmaceuticals [REGN] share price is $738.00. The Score for REGN is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • REGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $114.23
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

REGN Stock Price Chart

What is Regeneron Pharmaceuticals's stock price today?

  • The Regeneron Pharmaceuticals share price today is $738.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.42 Sell
Relative Strength Index (14 RSI): 44.35 Sell
Chaikin Money Flow: 638386 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.48 - 129.26) Sell
Bollinger Bands (100): (119.5 - 143.18) Sell

REGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -60.82 Sell
Relative Strength Index (14 RSI): 13.13 Sell
Chaikin Money Flow: -973600 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (767.55 - 916.07) Sell
Bollinger Bands (100): (904.84 - 1161.96) Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 109.13 Buy
20-day SMA: 118.03 Sell
50-day SMA: 122 Sell
200-day SMA: 130.03 Sell
8-day EMA: 111.53 Buy
20-day EMA: 115.85 Sell
50-day EMA: 121.84 Sell
200-day EMA: 126.04 Sell

REGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 759.51 Sell
20-day SMA: 815.56 Sell
50-day SMA: 948.17 Sell
200-day SMA: 1001.38 Sell
8-day EMA: 761.76 Sell
20-day EMA: 815.61 Sell
50-day EMA: 913.33 Sell
200-day EMA: 973.48 Sell

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.72 per share.

Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.42 per share, and an increase next year of $0.41 per share.

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regeneron Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):